Literature DB >> 3865224

Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats.

N G Moss, S L Powell, R J Falk.   

Abstract

The effect of acute intravenous infusion of cyclosporine (10 mg/kg) on efferent renal and genitofemoral nerve activity and afferent renal nerve activity was studied in anesthetized rats. All animals were studied after unilateral renal denervation and extracellular fluid volume expansion. Activity of both efferent sympathetic nerves was increased significantly by cyclosporine infusion (renal, 69%; genitofemoral, 60%). Afferent renal nerve activity was increased 82% after cyclosporine (P less than 0.05). Urine flow rate and both absolute and fractional sodium excretion from the innervated kidney were reduced 50% after cyclosporine infusion (P less than 0.01). Absolute and fractional sodium excretion from the denervated kidney were significantly increased after cyclosporine. Infusion of vehicle had no significant effect on any measured variable in innervated or denervated kidneys. These studies demonstrate the capacity of cyclosporine to increase efferent sympathetic nerve activity and afferent nerve activity. It is also shown that sodium retention resulting from acute infusion of cyclosporine can be attributed to the increase in efferent renal nerve activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865224      PMCID: PMC391475          DOI: 10.1073/pnas.82.23.8222

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Effect of sympathetic blocking agents on the antinatriuresis of reflex renal nerve stimulation.

Authors:  E J Zambraski; G F Dibona; G J Kaloyanides
Journal:  J Pharmacol Exp Ther       Date:  1976-08       Impact factor: 4.030

2.  [A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics].

Authors:  J FUHR; J KACZMARCZYK; C D KRUTTGEN
Journal:  Klin Wochenschr       Date:  1955-08-01

3.  Hypertension and convulsions in children receiving cyclosporin A.

Authors:  D V Joss; A J Barrett; J R Kendra; C F Lucas; S Desai
Journal:  Lancet       Date:  1982-04-17       Impact factor: 79.321

4.  Renal receptors in the rat sensitive to chemical alterations of their environment.

Authors:  G M Recordati; N G Moss; S Genovesi; P R Rogenes
Journal:  Circ Res       Date:  1980-03       Impact factor: 17.367

5.  Functional reinnervation and development of supersensitivity to NE after renal denervation in rats.

Authors:  R L Kline; P F Mercer
Journal:  Am J Physiol       Date:  1980-05

6.  Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation.

Authors:  K Atkinson; J Biggs; P Darveniza; J Boland; A Concannon; A Dodds
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

7.  Renal chemoreceptors.

Authors:  G Recordati; N G Moss; S Genovesi; P Rogenes
Journal:  J Auton Nerv Syst       Date:  1981-04

8.  Renorenal reflexes in the rat elicited upon stimulation of renal chemoreceptors.

Authors:  G Recordati; S Genovesi; D Cerati
Journal:  J Auton Nerv Syst       Date:  1982-09

9.  Single-unit and multiunit analyses of renorenal reflexes elicited by stimulation of renal chemoreceptors in the rat.

Authors:  P R Rogenes
Journal:  J Auton Nerv Syst       Date:  1982-09

10.  The influence of sodium status and furosemide on canine acute amphotericin B nephrotoxicity.

Authors:  J F Gerkens; R A Branch
Journal:  J Pharmacol Exp Ther       Date:  1980-08       Impact factor: 4.030

View more
  24 in total

Review 1.  Posttransplant diabetes and hypertension: pathophysiologic insights and therapeutic rationale.

Authors:  Moro O Salifu; Fasika Tedla; Serhat Aytug; Amir Hayat; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2008-06       Impact factor: 4.810

Review 2.  Cardiac transplantation. Selection, immunosuppression, and survival.

Authors:  L W Stevenson; H Laks; P I Terasaki; B D Kahan; D C Drinkwater
Journal:  West J Med       Date:  1988-11

3.  Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms.

Authors:  K I Blankenstein; A Borschewski; R Labes; A Paliege; C Boldt; J A McCormick; D H Ellison; M Bader; S Bachmann; K Mutig
Journal:  Am J Physiol Renal Physiol       Date:  2016-12-21

Review 4.  Central modulation of cyclosporine-induced hypertension.

Authors:  Hanan M El-Gowelli; Mahmoud M El-Mas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-11-29       Impact factor: 3.000

5.  Cyclosporine-induced nephrotoxicity in deoxycorticosterone-NaCl treated rats.

Authors:  J M Wyss; M S Mozaffari; P L St John; D R Abrahamson
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

6.  Vascular mechanisms of cyclosporin-induced hypertension in the rat.

Authors:  J B Roullet; H Xue; D A McCarron; S Holcomb; W M Bennett
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

7.  Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.

Authors:  D M Lanese; J D Conger
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study.

Authors:  Ping Gao; Xin-Lei Guan; Rui Huang; Xiao-Fang Shang-Guan; Jiang-Wei Luan; Mao-Chang Liu; Hua Xu; Xiao-Wen Wang
Journal:  Eur J Clin Pharmacol       Date:  2019-11-19       Impact factor: 2.953

9.  Functional effects on glomerular hemodynamics of short-term chronic cyclosporine in male rats.

Authors:  S C Thomson; B J Tucker; F Gabbai; R C Blantz
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

Review 10.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.